Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) shares, rose in value on Friday, May 30, with the stock price down by -0.03% to the previous day’s close as strong demand from buyers drove the stock to $30.51. Actively observing the price movement in the last trading, the stock
Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) concluded the trading at $31.24 on Friday, May 16 with a rise of 0.10% from its closing price on previous day. Considering stock’s 52-week price range provides that CRNX hit a high price of $62.53 and saw its price falling to
Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) traded at $30.95 at close of the session on Tuesday, May 13 and made a downward move of -7.11% on its previous day’s price. Crinetics Pharmaceuticals Inc has a market cap of $2.90 billion and is expected to release its quarterly
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.